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Abstract
In many analyses, one has data on one level but desires to draw inference on
another level. For example, in genetic association studies, one observes units of
DNA referred to as SNPs, but wants to determine whether genes that are com-
prised of SNPs are associated with disease. While there are some available ap-
proaches for addressing this issue, they usually involve making parametric as-
sumptions and are not easily generalizable. A statistical test is proposed for testing
the association of a set of variables with an outcome of interest. No assumptions
are made about the functional form relating the variables to the outcome. A gen-
eral function is fit using any statistical learning algorithm, with the SuperLearner
algorithm suggested. The parameter of interest is the cross-validated risk and this
is compared to an expected risk. A Wald test is proposed using the influence
curve of the cross-validated risk to obtain the variance. It is shown both theoreti-
cally and via simulation that the test maintains appropriate type I error control and
is more powerful than parametric tests under more general alternatives. The test
is applied to an MS candidate gene study. Three separate analyses are performed
highlighting the flexibility of the approach.
1 Introduction
In many statistical problems one desires to relate a set of variables to an outcome. For
example, it is typical in the social sciences to have data on race, income, education etc. and
want to draw inference about the relationship between some outcome and socio-economic
status (SES). SES itself is not observed but is instead a combination of the aforementioned
variables (as well as others). Some approaches for answering such a question include F-tests
and likelihood ratio tests, Fishers’s method for combining p-values [Fisher 1948], and prin-
cipal components regression. In addition to these generalized approaches, many discipline
specific measures have been developed. For example, in psychology it is common to come
up with “scores” on different survey instruments. While useful all of these methods suffer
from two primary limitations. Firstly, they often rely on parametric modeling assumptions
and secondly they often do not take into account the complex relationships of the variables.
Since the underlying relationship between a set of variables and an outcome is usually
quite complex and unknown, ideally, instead of specifying a model relating the set of
variables to the outcome one would be able to search for the best relationship. Typical
statistical learning and prediction methodology is well suited for solving such problems.
Statistical learning algorithms apply a basis function (or set of basis functions) to the data
to find the best relationship to the outcome. While the best algorithm will depend on the
true relationship between the predictor variables and the outcome, most are well suited for
situations where the relationship is complex and/or of high dimension. Typically the focus
is on trying to get the best estimate of the function relating the data to the outcome, but
in recent years there has been a growing emphasis on variable importance (VI). However,
most of the VI measures are ad-hoc and do not have sound statistical properties with a
clear parameter of interest, though there is some work trying to formalize VI and attach
statistic properties for more targeted analyses [van der Laan 2006]. Moreover, like with
inferential statistics there is not a best means to relate a group of variables to an outcome.
The goal of this paper is to establish a statistical test for assessing the relationship
between a set of variables and an outcome. Using tools from statistical learning, a general
function is estimated. Others have assessed this relationship using a full permutation
test (e.g. Radmacher et al. [2002]; Birkner et al. [2005]; Chaffee et al. [2010]), however,
for all but the simplest algorithms, this is computationally infeasible. Instead, a simple
to calculate statistic is proposed. The parameter to be evaluated is the risk between a
predicted value and the observed value. This observed risk is compared to an expected
risk via a Wald test. A rejection of the null hypothesis that the observed risk is less than
the expected risk indicates that the prediction is better than would be expected by chance
and that the set of predictors are related to the outcome.
The need for such a statistic can be motivated from two different perspectives: infer-
ential statistics and statistical learning. From an inferential statistics perspective, such
an approach can be used to test the association of a group of variables and an outcome
(as motivated in the outset). Typically, the group of variables represent an unobserved
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construct such as SES, a gene, or a stock index. From a statistical learning perspective,
the current statistical test represents a means to test whether the prediction derived from
a machine learning algorithm is better than what would be expected by chance. This is a
question that is not typically asked within the machine learning literature as practition-
ers generally assume that the set of predictors is related to the outcome and a significant
prediction can always be derived. While this is not an unreasonable assumption, with the
growing ubiquity of prediction methodology, these algorithms are more often being applied
to data that may not actually have predictive power (this is particularly true within genetic
epidemiology). Therefore, the current method should have broad interest and applicability
to both those who are primarily interested in inference as well as those that are primarily
interested in prediction.
The paper is organized as follows. In section 2 some preliminaries on statistical learning
and loss based estimation via cross-validation are presented. In section 3 the statistical test
is proposed with discussion of how to estimate each of the parameters. The next section
provides a brief overview of related literature. Section 5 shows some basic simulation
results. Section 6 presents an application to genetic epidemiology data. Section 7 provides
some concluding thoughts.
2 Preliminaries
We begin with the observed data Wi = (Yi, Xi) ∼ PW , i = 1, . . . , n. The Yi are the outcome
of interest and Yi ∈ <1. The Yi can be continuous or binary. The Xi are the covariates, a
p−dimensional vector, where Xi ∈ <p. We relate X to Y by the functional transformation
f(·):
E(Y |X) = f(X)
P (Y = 1|X) = f(X) for Y ∈ {0, 1} (2.1)
In (2.1) we make no assumptions about the function form of f(·).
2.1 Statistical Learning
Statistical learning is concerned with estimating f(·) for the purposes of predicting future
outcomes based on an observed covariate vector. All statistical learning algorithms provide
a different means of Wrt to Paul’s work it is definitely a more computationally friendly
version b/c it doesn’t require a complete permutation. I think it can also be viewed as
an extension of yours and Sandrine’s workestimating this function. Table 1 lists a range
of different learning algorithms. Each algorithm applies a different type of basis function
to the data. All algorithms also have a different set of tuning parameters (many have
multiple). Changing the tuning parameters optimizes the algorithm for the specific data
problem.
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Learner Type of Function Tuning Parameters Speed
Regression Linear Relationship Variables in Model Fast
Lasso/Ridge Regression Penalized Regression Penalty Moderate
Nearest Neighbors Classification based Number Neighbors Fast
on Proximity
CART Tree Tree Depth Moderate
Splines Piecewise Functions Knots Fast
Support Vector Machines Transformation of Transformation Slow
Output Space
Table 1: Different Learning Algorithms
Not all algorithms are appropriate for all data problems. For example, if there is a
lot of additive structure in the data a linear algorithm will do much better than a tree
based algorithm. Conversely, if there are many interactions, then a tree based algorithm
would be preferable. Since the choice of best algorithm is dependent on the true underlying
function, f(·), which is unknown, it is impossible to know which is best to use.
With this limitation in mind, as computational power has increased, there has been
a growing use of ensemble based learners. Ensemble learning is a process of combining
multiple learners (typically weak ones) together into one meta learner. There are many
different types of ways to ensemble algorithms with the primary methods being: bagging,
boosting, Bayesian model averaging and stacking. Ensemble algorithms differ in what their
base learners consist of and how the algorithms are combined (i.e. the weights placed on
each algorithm). For example the Random Forests algorithm [Breiman 2001] is an ensemble
based algorithm where the base learners are unpruned CART trees and they are combined
via bagging, a process of adding equal weight to all learners.
Different ensemble algorithms will have different strengths and weaknesses. In the
present work, the goal is to use the algorithm that best estimates the underlying function
f(·). The algorithm that has been found to be most adapted for this problem is the
SuperLearner (SL) algorithm [van der Laan et al. 2007]. SL is an algorithm based on
stacking [Wolpert 1992]. In stacking based algorithms a library of algorithms is applied
to the data and each algorithm provides a predictions of the outcome via cross-validation
(CV). The predictions for each observation are stacked, creating a matrix of predicted
outcomes for each of the j learners. The true outcome is regressed onto the predicted
values. The derived coefficients provide the weights for each algorithm.
In the implementation of SL, available in SuperLearner package in R, the regression
performed is a non-negative least squares and the coefficients are scaled to sum to 1. Other
authors [Breiman 1996; Ting and Witten 1997] have similarly found non-negative least
squares to be the optimal majorizing function. While typical implementations of stacking
involve using similar base learners with different tuning parameter settings, van der Laan
3
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et al. advocate using a full library of different types of learners covering a range of basis
functions. The authors were able to show that stacking satisfies certain oracle properties
which we repeat here:
Oracle Inequalities: Let do(ψ,ψ0) = EPX{L(X,ψ) − L(X,ψ0)} be the risk difference
between the candidate estimate ψ and the true parameter value ψ0. Also, suppose the
P{(Ψˆk(Pn) ∈ Ψ) : ∀k} = 1. Assume:
A1: L(X,ψ) is uniformly bounded
A2: The variance of the ψ0-centered loss function (L(X,ψ)−L(X,ψ0)) can be uniformly
bounded by its expectation uniformly in ψ.
then, for any λ > 0:
Ed0(ΨKˆ(Pn)(Pn,T (V )), ψ0) ≤ (1 + 2λ)Ed0(ΨK˜(Pn)(Pn,T (V )), ψ0) + 2C(λ)
1 + log(K(n))
np
where p is the proportion of the observations in the validation sample and C(λ) is a constant
defined in van der Laan et al. [2006].
These results imply that the SL performs as well as the oracle selector in terms of
expected risk difference and as long as the number of candidate learners (K(n)) is poly-
nomial in sample size, the SL is the optimal learner. Moreover, if one of the candidate
learner searches within a parametric model and that model contains the truth, then the
SL attains an almost parametric rate of convergence log n/n. This makes the SL an ideal
learner when the true underlying function is unknown.
In practice, implementing the SL is fairly straightforward. The main tuning parame-
ters include selecting the candidate library, the number of CV splits, and the majorizing
function. The majorizing function, as mentioned, is typically non-negative least squares.
While the larger the number of CV splits the better the estimate of the function, there
is obviously a computational trade off. Typically 10-fold or 20 fold CV has been found
to be appropriate. The most important aspect is the candidate library. Again, while one
may say “the more the better” (up to a limit), in practice fitting each candidate can be
highly computational and it is worth being judicious in the choice of candidate learners.
Generally, then, it is best to apply SL with a library that spans a range of basis functions.
One final note about the computation is that it is fairly straightforward to implement the
SL either within a cloud environment or across nodes in a parallel environment.
2.2 Loss Based Estimation via Cross-Validation
Once the learning algorithm is fit to the data a prediction, fˆ(Xi), is generated for each
observation, Yi. The goal in prediction is to minimize the risk over the training set:
argminfE[L(Y, fˆ(X)] (2.2)
4
http://biostats.bepress.com/ucbbiostat/paper274
The “harder” fˆ(·) is fit to the data, the greater the potential for over-fitting, referred to
as the optimism, and, consequentially under-estimating the risk [Hastie et al. 2009]. There
are two main approaches for correcting for over-fitting. The first is by directly estimating
the optimism and adding this to the estimated training error (e.g. AIC, BIC, MDL). The
other is to directly estimate the test error (e.g. CV, Bootstrap methods). Direct methods
are useful when the number of basis functions (effective number of parameters) are easily
calculable (e.g. linear models, regularized regression). For more complex methods (includ-
ing all ensembles), such calculations are intractable. CV methods provide the simplest
approach to obtaining an honest estimate of fˆ(X), and consequently the risk.
In all CV methods, the data are divided into a training and validation set. The estima-
tor is computed (trained) on the training set and then tested (validated) on the remaining
validation set. This process is iterated, allowing each observation to be part of the valida-
tion set, providing an unbiased estimate of the risk of the estimator [Dudoit and van der
Laan 2005].
Using notation from Dudoit and van der Laan, we define a binary random vector,
Bn = (Bn(i) : i = 1, . . . , n) ∈ {0, 1}n, independent of the empirical distribution Pn. A
realization, Bn(i) represents an indicator of whether an observation is in the training or
validation set:
Bn(i) =
{
0, ith observation Xi is in the training set,
1, ith observation Xi is in the validation set,
(2.3)
Let P 0n,Bn and P
1
n,Bn
denote the empirical distributions of the training and validation sets,
respectively, and let the number and proportion of observations in the validation sets be
denoted by n1 ≡
∑
iBn(i) and p = pn ≡ n1/n, respectively. Then a definition of the
cross-validated risk estimator for ψn = Ψˆ(Pn) is
θˆpn,n ≡ EBnΘ(Ψˆ(P 0n,Bn), P 1n,Bn)
= EBn
∫
L(x, Ψˆ(P 0n,Bn))dP
1
n,Bn(x)
= EBn
1
n1
n1∑
i:Bn(i)=1
L(Xi, Ψˆ(P
0
n,Bn))
(2.4)
where Ψˆ(P 0n,Bn) represents the estimator of the parameter ψ based on the training set.
The distribution of Bn determines the type of CV. The most common type of CV is
V-fold cross-validation. In V-fold CV the learning set is randomly divided into V mutually
exclusive sets of approximately equal size. Each set is then used in turn as a validation
set (see figure 1). The distribution of Bn places mass 1/V on each of V binary vectors
such that
∑
i b
v
n(i) ≈ n/V ∀ v and
∑
v b
v
n(i) = 1 ∀ i. Other forms of cross-validation
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Figure 1: Illustration of 4-fold CV where n = 8 and n1 = 2. In each cycle, 6 observations
are used to train the learner and 2 are used to test or validate it. Courtesy of maxdama.com
include Leave-one-out cross-validation, Monte Carlo cross-validation and Bootstrap-based
cross-validation [Dudoit and van der Laan 2005].
Dudoit and van der Laan showed that the risk estimate provided through CV is asymp-
totically linear with appropriate assumption (see Theorem 3 in their paper) and has influ-
ence curve (IC):
IC ≡ L[Y, f(X)]− θ ⇒
θˆ ∼= 1
n
n∑
i=1
L[Yi, fˆ(Xi)]− θˆ
(2.5)
The benefit of defining the IC of a parameter is that one can use the variance of the IC to
obtain the variance of the estimator. Dudoit and van der Laan use this result to construct
6
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confidence intervals for the risk estimate
θˆn ± z1−α/2
σn√
n
where θˆn is the estimated cross-validated risk and σn is the standard deviation of the
cross-validated loss. Asymptotically the observed standard deviation, σˆ, is an appropriate
estimator. Bengio and Grandvalet [2004] showed that while there is no unbiased estimate
for σ in finite samples, it does converge to the observed standard deviation fairly rapidly
(see Section 4 for discussion).
3 The proposed test statistic
The parameter of interest, θ, is the risk from our prediction algorithm:
θ ≡ EL(Y, f(X))
θˆ ≡ EL(Y, fˆ(X)) (3.1)
based on the model defined in (2.1). While Dudoit and van der Laan [2005] focused on
generating confidence intervals for the observed risk, θˆ, the present interest is in hypothesis
testing. We can test the hypothesis:
Ho :θ ≥ θ∗
Ha :θ < θ
∗ (3.2)
This is a one-sided hypothesis test of whether the observed risk, θˆn is less than some
expected risk under a null hypothesis, θ∗n. We define
θ∗ ≡ E[L(Y, f(X))]s.t.Y ⊥ X (3.3)
We can then use the same asymptotic linearity result and define a Wald-type statistic, with
parameter ψ:
Z =
ψˆ
√
n√
ˆvar(IC(W ;ψ)
=
θˆn − θˆ∗n√
var(θˆn − θˆ∗n)
∼ N(0, 1)
(3.4)
This will be a one-tailed test as we are only interested in the case where θˆn < θˆ
∗
n.
From (3.4) there are three values that need to be estimated:
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• The estimated risk: θˆn
• The estimated risk under the null: θˆ∗n
• The variance of the difference of the two: var(θˆn − θˆ∗n)
3.1 The Observed Risk
The observed risk is the simplest value to estimate. Whereas any loss function can be used,
a loss that has certain asymptotic properties will be needed to allow for the use of the IC to
calculate the asymptotic variance. Based on the work of Dudoit and van der Laan [2005],
this includes most any loss, with the notable exception of misclassification loss.
For mathematical simplicity, that will be seen later, squared error (`2) loss is used, with
the estimated risk being:
θˆn ≡ EnL(Y, fˆ(X)) ≡ En(Y − fˆ(X))2 (3.5)
3.2 The Null Risk
The null risk is the expected value of the loss between the observed outcome and the pre-
dicted outcome, when the set of covariates, X, is independent of the outcome, Y . The most
direct way to estimate this is by permuting the X values and retraining the predictor. For
all but the simplest prediction algorithms, though, this can be computationally infeasible.
However it is possible to estimate this value. We need:
θ(P ∗) = EP ∗ [Y − f(X)]2
Assuming that f(X) is of fixed form, and the learning algorithm has an intercept:
Ef(X) = µY = EY
Therefore, we get:
EP ∗ [(Y − µY + µY − f(X))2]
= EP ∗(Y − µY )2 + EP ∗(f(x)− µY )2 + 2EP ∗
(
(Y − µY )(µY − f(X)
)
So:
θ = var(Y ) + var
(
f(X)
)− 2cov(f(X), Y )
θ∗ = var(Y ) + var
(
f(X)
) (3.6)
Thus a test of the null that θ = θ∗ is a test of the cov
(
f(X), Y
)
= 0.
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3.3 The Variance of the Difference of Risks
The final consideration is defining the variance of the difference of θˆn & θˆ
∗
n. Using the
property of ICs we have:
var(θˆ − θˆ∗) = var(IC[θˆ]− IC[θˆ
∗])
n
(3.7)
Therefore we need to define the IC for θˆ and θˆ∗. We note the parameter of interest can be
expressed as:
ψ ≡ E[Y − f(X)]2 − E[Y − EY ]2 − E[f(X)− E(f(X))]2 (3.8)
This is simply the difference of three loss functions. Dudoit and van der Laan [2005],
provided the framework for calculating the influence curve for any general loss function,
noted in (2.5). Therefore:
IC(W ;ψ) = IC1 − IC2 − IC3
=
(
L[Y, f(X)]− θ)− (L[Y,EY ]− θY )− (L[f(X), Ef(X)]− θf(X)) (3.9)
By substituting the appropriate loss function (in this case `2) and taking the variance of
(3.9) one can calculate the inference for the test statistic. There are now all of the elements
of the test statistic and referring back to (3.4) we can write:
Z =
ψˆ
√
n√
ˆvar(IC(W ;ψ)
=
θˆn − θˆ∗n√
var(θˆn − θˆ∗n)
=
√
n
[
En(Y−fˆ(X))2−En(Y−Y¯ )2−var(fˆ(X))
]√
var
(
En[(Yi−fˆ(Xi))2+θˆ]−En[(Yi−µ)2+σˆ2Y ]−En[(fˆ(Xi)−Efˆ(Xi))2+σˆ2fˆ(X)]
)
(3.10)
The statistical test as constructed will be unbiased for predicting on an independent
sample. However, while asymptotically the proposed test statistic will approach N(0, 1)
in practice the estimated variance a bit too small. This is due to the excess correlation
induced by cross-validation (see [Bengio and Grandvalet 2004]). Simulations showed that
the asymptotics do not fully kick in until extremely large samples (n > 1×107). Grandvalet
and Bengio [2006] proposed a finite sample correction (see section 4). Based on experi-
mental results it was found that the variance in (3.10) underestimated the true variance
by a factor of 2 (see figure 2 in section 5). This is obviously a less than ideal solution and
current work involves trying to determine a more theoretical finite sample correction.
To calculate the statistic in R code:
9
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sqLOSS <- function(x,y)(x-y)^2
predTestL2 <- function(pred,Y,LOSS = sqLOSS){
n <-length(Y)
ll <- LOSS(pred,Y) ###\hat\theta
lo <- LOSS(mean(Y),Y) - LOSS(pred,mean(pred)) ###\hat\theta^*
LossD <- mean(ll - lo)
varIC <- var(ll - lo)*2
Z <- LossD*sqrt(n)/sqrt(varIC)
return(Z)
}
3.4 A Permutation Based Test
It is also possible to construct a significance test via the permutation distribution. To
test the independence of Y and the p-vector X one could permute the Y and continually
retrain the predictor [Radmacher et al. 2002]. However, for the most part this is too
computational. Alternatively, one can test the independence of Y and fˆ(X). To do so:
1. Train the predictor to obtain fˆ(X)
2. Calculate θˆ =
∑
i L(Yi, fˆ(Xi))
3. Permute the Yi b times and calculate θˆ
∗
j =
∑
i L(Y
∗
i , fˆ(Xi)) for j ∈ 1 . . . b
4. The permutation based p-value is 1b
∑
j I
[
θˆ < θˆ∗j
]
The choice of b will depend on the desired precision of the empirical p-value, with
stronger associations requiring larger b. To calculate this in R code:
predTestPerm <- function(pred,Y, p = 1000, LOSS = sqLOSS){
Yp <- replicate(p, sample(Y))
mZ <- median(LOSS(pred,Y))
Zp <- apply(Yp,2,function(x)median(LOSS(pred,x)))
pval <- 1 - sum(mZ < Zp)/p
return(pval)
}
4 Previous Work with Assessing Prediction
In a general sense, the proposed test can be considered as analogous to an F-test, used in
linear regression. Both approaches aim to test the goodness-of-fit of a fitted function based
10
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on the residual fit. The primary distinction is that while an F-test relies on the correctly
specifying the parametric form of f(·), the proposed test can be seen as a semi-parametric
alternative that does not depend on a specified functional form (see Figure 5 in Section 5).
There has been some related work assessing the significance of a prediction. The work of
Dudoit and van der Laan [2005] focused on providing a theoretical basis for calculating the
standard-error of the CV risk estimate for the purpose of constructing confidence intervals.
Their work focused on the asymptotic properties, showing that it is both consistent and
asymptotically linear.
Bengio and Grandvalet [2004] were also interested in constructing confidence intervals
for the CV risk estimate, however they focused on finite samples. The authors showed both
theoretically and via simulation that in finite samples it is not possible to get an unbiased
estimate of the variance of the cross-validated risk estimate. They broke down the variance
into three components:
(1) The variability of the prediction within each validation block
(2) The covariance between predictions within each block
(3) The covariance between predictions in different blocks
The first value is the quantity of interest, however, simply taking the empirical variance
of fˆ(X) is biased by the other two quantities. However, the authors showed, with modest
sample sizes (n > 100− 500) these two values go to 0, resulting in the desired value. The
authors proposed a corrected test statistic based on an assumed maximum between block
correlation of 0.7 [Grandvalet and Bengio 2006]. This correction is similar to the proposed
correction in the current work. The primary limitation of their formulation is that they
construct a t-test against a fixed value. However, as shown above, if one wants to test
against an expected risk, it is necessary to estimate θ∗ and therefore the variance of the
estimate also needs to be considered.
Dietterich [1998] showed also that it is only in small samples one needs to be concerned
with the variance estimates of the cross-validated risk. This work provides further finite
sample justification for the work of Dudoit and van der Laan and much of the present
discussion.
Other work includes Radmacher et al. [2002] who laid a general framework for assessing
the prediction in micro-array studies. The authors advocated permuting and then refitting
the learner, to assess the risk estimate via cross-validation. However, they were working
with much simpler learners. Others have used this full permutation approach for testing
genetic pathways [Birkner et al. 2005] and perfoming gene set tests [Chaffee et al. 2010].
Lusa et al. [2007] noted that simply calculating the odds-ratio on a two-by-two table led
to inflated type I error. This was also noted by Lee [2007]. This observation conforms to
the theory presented in Dudoit and van der Laan, which showed that misclassification loss
is not an appropriate loss function to use for the present work.
11
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5 Simulations
To examine the behavior of the test statistic a series of simulations were undertaken. It
is re-noted that the Z-test is a one-tailed test where the more negative the test statistic,
the more significant the association. The first simulation was aimed at examining the need
for a correction of the test statistic. Figure 2 shows the true variance of θˆ − θˆ∗ compared
to both the asymptotically calculated variance as well as the corrected variance. One-
thousand simulations were performed using full terms regression as the only learner, and
10-fold CV (larger folds of CV were performed and did not impact the results). Both the
sample size and the number of parameters in the model were varied. Results suggest, that
the ratio between the true variance and the asymptotic variance is fairly consistent at 2.
The absolute variance decreases as sample size increases and increases with the number of
parameters. The great decrease in the absolute difference of the expected and estimated
variance with large sample, suggests that the asymptotics are working, but the relative
difference, indicates that the correction is of value.
Once determining an appropriate correction for the test statistic, the next series of
simulations aimed to understand the statistic itself. The first simulation explored the
null situation where Y ∼ N(0, 1) was independent of X ∼ N(0, 1) ∈ <p. One-thousand
simulations were run, using 10 predictors, under three different sample sizes (100, 2, 000,
10, 000). Linear regression was the only model used to estimate f(X). As the sample size
increases the test statistic becomes more normally distributed. Moreover the correction
becomes less important. For the permutation test, a Z-quantile for the empirical p-value
was calculated (see Figure 3).
12
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Figure 2: The true variance and estimated variance of θˆn− θˆ∗n across 1,000 simulations. In
the left hand figure, the number of parameters is fixed at 10 and the number of people is
varied from 100 to 10,000. In the right hand figure the number of people is fixed at 10,000
and the number of parameters is varied. Unsurprisingly the variance decreases with sample
size and increases with the number of parameters. Of greater interest, the ratio between
the asymptotically estimated variance and the true variance remains relatively constant at
2, though decreases in absolute terms with increasing sample size. Finally, the increase in
variance due to the number of parameters appears to be linear in p.
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Figure 3: Behavior of test statistic with increasing sample size. One-thousand simulations
performed with continuous X and Y and no association between them. 10 predictors are
used. For larger n both the asymptotic and the corrected test statistics become more normal
with variance 1. The uncorrected is slightly anti-conservative in the extreme (negative)
tails highlighting the need for the correction at lower sample sizes. The permutation p-value
have been transformed to a normal distribution for comparison and maintains appropriate
error control.
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Secondly, the test statistic was examined under an alternative scenario where there is
a true relationship between Y & X. In this simulation, p = 10, and different sample sizes
were used. Y = X1 + , with Y ⊥ X2 . . . X10. For simplicity, the corrected test statistic
was calculated. Figure 4 shows the simulation results. While, the test has little power in
low sample size (n = 100), the test gains power as the sample size increases, and maintains
a N(µ, 1) distribution.
To illustrate the comparison to the F-test, two more simulations were undertaken, both
under an alternative model. In the first, Y = X1 +  again. In the second, Y = X1 ∗X2 + ,
an interaction between two of the X covariates but with no main effects. To calculate
the F-statistic the full main effects model was fit. In scenario I, it is expected that the
F-statistic should capture the Y,X1 relationship. However, in simulation II, the model is
now misspecified. To calculate the proposed test, a SuperLearner was fit, using a step wise
algorithm and an intercept function.
The average p-values for each scenario are calculated and presented in figure 5. Both
methods are able to detect the association when there is a main effect term in the model.
However, once there is only an interaction, the F-test loses all of its power due to the
misspecified model. The SuperLearner approach is able to flexibly search for the best
model and consequently has ample power to detect the association. It is thus flexible
against semi-parametric alternatives, giving this approach its power.
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Figure 4: Distribution of the test-statistics when there is an association. Again linear
regression is the only model used to estimate f(X). The corrected test-statistic is calcu-
lated. As the sample size increases, the test statistic becomes both more significant (more
negative) and approaches N(µ, 1).
16
http://biostats.bepress.com/ucbbiostat/paper274
Main Effect Interaction
My test
F−Test
−
lo
g 1
0 
p−
va
lu
e
0
2
4
6
8
10
Figure 5: Average − log10 of the p-values for the two “alternative” simulation settings.
In the first, there is a a true main effect term in the model and both the F-test and the
proposed test are able to detect it. In the second, there is only an interaction, and the
miss-specified regression model is not able to detect the association, while the more flexible
SuperLearner based method is able to find the right model and detect the association.
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6 Application to genetic data
A typical means of studying the genetic causes to diseases is via SNP association studies.
This design involves recruiting 1000’s of people with and without a disease of interest,
referred to as cases and controls respectively. Each individual is typed on a set of single
nucleotide polymorphisms (SNPs). Each SNP represents a single base pair of DNA where
there is a degree of variation across the population (most DNA is fixed and does not vary).
Genes are made up of 100s or 1000s of base pairs of DNA. Amongst these bases there will be
dozens or 100s of SNPs. In Genome Wide Association (GWA) studies individuals may be
typed on up to 1 million SNPs across the genome, aiming to capture ones common genetic
variation (on the nucleotide level). In more focused candidate gene studies individuals may
be typed on 10’s of thousands of SNPs aimed at well characterizing specific genes. These
studies represent an a hypothesis-free search across the genome for regions of interest to
be followed up on.
For the most part GWAs have been successful at identifying SNPs, and be extension
genes, associated with many common diseases [WTCCC 2007]. However, it is not presumed
that any associated SNP is itself causal. An associated SNP may be correlated (referred to
as in linkage disequilibrium [LD]) with the true causal variant, located within or near the
same gene. Therefore all results need to be confirmed via replication. Moreover, since the
studies are initially exploratory (until replication has occurred) the true unit of interest
the gene in which the SNP lies. This has led towards the recognition of the need for gene
based tests [Neale and Sham 2004].
In recent years there has been growth of gene based tests of association (see Beyene et al.
[2009] for a recent review). These methods can roughly be broken down into (i) clustering
and PCA based approaches and (ii) logistic modeling and combining marginal p-values.
The method used in the popular and freely available software PLINK [Purcell et al. 2007], is
a variation of Fisher’s Method [Fisher 1948] that uses the permutation distribution to assess
significance. However, most of these methods suffer from one primary limitation: they rely
on marginal p-value (as calculated by a χ2 test) to assess the gene based association.
While marginal testing has been somewhat successful in detecting associations, and is
(more importantly) computationally simple, it does not well capture complex associations.
SNPs may interact or be involved in complex joint associations with other SNPs [Heidema
et al. 2006]. Therefore, methods dependent on typical marginal tests may be ill suited for
creating gene based tests.
One can consider the proposed to test as another means of performing a gene based
test for association. In this setting, the observed units would be the SNPs and the unit of
interest is the gene which they comprise. A prediction model relating the SNPs in a gene
to disease status serves as a test for association for the entire gene. This point is illustrated
first via simulation and then in application to a candidate gene study.
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6.1 Simulation Study
A more comprehensive simulation study was undertaken to explore the use of the test
statistic for candidate gene studies. Fifty simulations were performed. In each simulation
440 genes were simulated, consisting of 10 SNPs. Each of the 10 SNPs were independent
and had a minor allele frequency of 0.3. In this sense a realistic genetic structure was
not simulated, where one would expect complex correlation between SNPs and varying
minor allele frequencies. However, to explore the performance of the method this was not
necessary.
Of the 440 genes in each dataset, 40 (10%) of the genes were associated with the out-
come. The goal of the simulation was specifically explore how the proposed test compares
to standard methods when there is a complex association. Four different association models
were used:
Additive: P (D|SNPsGene) = β(X1 +X2 +X3) with Xi ∈ {0, 1, 2}
Dominant: P (D|SNPsGene) = β(X1 +X2 +X3) with Xi ∈ {0, 1/2}
Recessive: P (D|SNPsGene) = β(X1 +X2 +X3) with Xi ∈ {0/1, 2}
Interaction: P (D|SNPsGene) = β(X1 ∗X2) with Xi ∈ {0, 1, 2}
These represent genic style associations where multiple SNPs within a gene lead to an
increase in the probability of disease.
For each dataset three measures of association were calculated. First, the marginal
association for each of the 4, 400 SNPs was calculated via the allelic χ2-test. This is the
typical test for association in genetic epidemiology studies. It is a 1-df test that compares
the frequency of the alleles between those with disease and those without. The second
measure of association was the variation of Fisher’s Method for combining p-values. To
calculate the p-value, 10,000 permutation were performed. Finally, the current test was
used to estimate the function
P (D|SNPsGene) = f(SNPs)
A SuperLearner was fit using a library of: k-Nearest Neighbors, a logistic regression step
function, RandomForests, LASSO and an intercept function, using 10 fold CV to both fit
and validate the function. The corrected parametric statistic was used to calculate the
p-value.
For each method the false discovery rate (FDR) was controlled using the Benjamini-
Hochberg (BH) [Benjamini and Hochberg 1995] procedure at a level of 5%. The average
power and error-rate across the 50 simulations was calculated for each procedure. For the
marginal testing, if one of the SNPs in the gene passed the significance threshold, then the
entire gene was declared significant.
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Figure 6: Bar plot comparing three methods for assessing the association of a gene. The
proposed test has both the greatest power (∼ 57%) lowest FDR (∼ 1.8%) The FDR was
controlled at a level of 5%. Marginal testing proved to be fairly successful, though the
greater multiple testing burden incurred by the 10-fold increase in the number of tests
makes it less powerful. Fisher’s Method was not able to maintain a high significance level.
Figure 6 shows the power and FDR for the three methods. The proposed test has
the most amount of power (57% vs. 50% & 1%) as well as the lowest error-rate. While
marginal testing was fairly successful, the extra multiple testing burden incurred by the
extra tests decreased its power. It should be noted, that in an actual association study,
this burden would be even greater as most genes have many more than just 10 SNPs.
Finally, Fisher’s Method was least successful, this owes to the duel fact that it only looks
at marginal associations and considers all tests simultaneously, while the proposed method,
looks at the joint effects of only those tests of importance.
These results should not necessarily be interpreted that the proposed test is uniformly
more powerful than these or other methods. The proposed statistic is an omnibus test, and
only a few types of causal models were explored. For example, if only one SNP for a given
gene were causal, then the marginal test would be most powerful. Likewise, if most of the
SNPs for a given gene were associated than Fisher’s Method would have more power. The
value of the present statistic, though, is that it does not require one to specify a specific
model, but search for the best fitting one, while still maintaining adequate power.
To illustrate this a second simulation was undertaken. As opposed to a complex as-
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sociation, only one SNP was associated per gene. Moreover, the marginal p-value was
simulated to be approximately 1×10−8, the standard cut-off for genome wide significance.
One thousand genes were simulated, and the median the p-value for the associated SNP
was 8.5 × 10−9. The median p-value on the gene-based test, was 1.6 × 10−4. This shows
that even when the causal mechanism favors the marginal test, there is still ample signal to
find an association via this more flexible approach. For more complex associations, as well
as for larger datasets with greater multiple testing burden, this difference will decrease.
6.2 Data Analysis
To examine how this methods works with real data, three analyses were performed using
a data set derived from a candidate gene study. The first was a typical analysis to deter-
mine which genes were associated with disease. The second was aimed at exploring the
association of a genetic pathway. The third is a more unique cluster based analysis.
Data for all analyses comes from a 2007 candidate gene study from the International
Multiple Sclerosis Genetics Consortium. Multiple Sclerosis (MS) is an auto-immune disease
known to have a strong heritable component based on epidemiological studies [Oksenberg
and Barcellos 2005]. The major histocompatibility complex (MHC) region of chromosome
6 has long been known to be associated with MS, however few other genes have been
definitively identified.
The goal of the 2007 was to follow-up on suspected MS genes. The data collection has
been described previously [IMSGC 2010]. In brief, the data consisted of 1, 379 controls and
1, 343 cases. Data were collected on 52, 801 SNPs across 9552 genes. After data cleaning
there were 46, 057 SNPs.
6.2.1 Candidate Gene Study
The first analysis was aimed at detecting which genes are associated with MS. All genes
that had at least 8 SNPs in them and were not on chromosome X or within the MHC were
selected. Chromosome X genes were dropped to avoid gender effects, while MHC genes
were dropped since the goal was to detect genes that were not known to be associated with
MS. This left 1, 254 genes comprising 25, 362 SNPs.
The three methods for association were calculated as in the simulation study: the gen-
eralized method, the mean of the p-values (Fisher’s Method) and simple marginal testing.
For the generalized method, a SuperLearner was fit to estimate the function using the same
candidate learners as above, including also, Support Vector Machines and PolyClass. For
the mean of p-values, 10, 000 permutations were used, performed in PLINK [Purcell et al.
2007]. For marginal testing, the minimum p-value for each gene was recorded.
After controlling for multiple testing using the BH-FDR, none of the measures of asso-
ciation provided an FDR below 10%, suggesting that the smallest observed p-values would
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Figure 7: Distribution of test statistic for all genes. Left is a density plot while the right is
a qq-plot. The plots suggest that there are no greater associations that would be expected
by chance.
be expected simply by chance. Figure 7 shows the distribution of the test statistic across
the 1254 genes, both as a density plot and qq-plot. This further reflects that even though
small p-values were observed, these conform with what would be expected.
While it is not possible to reject the global null of no genes being associated, it is
still of value to explore the most significant genes. Table 2 lists all the genes that had
a p-value less than .01 on the proposed test. Also listed are their p-values for Fisher’s
Method as well as the smallest marginal p-value. From the table, it is clear that some
genes had strong association regardless of the method used. These include STAT4, IL7
and CLEC16A. Unsurprisingly, IL7 and CLEC16A have previously been identified as MS
genes [Hafler et al. 2007]. In this sense, the proposed method is able to replicate previous
findings. However, the other genes, while showing some marginal association, would not
be detected by typical methods. This suggests, that if truly associated, the mechanism is
more likely more complex than a single SNP association. Also noteworthy, is that the size
of the gene appears to be independent of the strength of association. Both small and large
genes had strong associations.
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Gene Chr Num SNPs Gene P-val Mean P-val Min SNP P-val
STAT4 2 139 0.099 0.006 2.86× 10−5
EFNA5 5 10 0.099 0.386 0.056
MAP1B 5 13 0.005 0.379 0.055
IL7 8 73 0.009 4.0× 10−4 2.04× 10−5
RBM17 10 77 0.009 0.310 0.021
IRF7 11 8 0.006 0.044 3.49× 10−4
CLEC16A 16 14 0.005 1.0× 10−4 1.08× 10−5
MYO1D 17 9 0.004 0.165 0.075
APP 21 9 0.005 0.104 0.044
Table 2: All Genes that had a p-value less than .01 on the gene based test. The p-value
based on Fisher’s Method as well as the minimum marginal p-value is also shown. The
genes highlighted in red probably would not have been detected by alternative methods.
Other genes, such as IL7 & CLEC16A not surprisingly have previously been associated with
MS.
6.2.2 Pathway Analysis
Using the same dataset, a second analysis was undertaken. Instead of looking at individual
genes, whole genetic pathways were explored. Many genes have shared biological functions,
referred to as genetic pathways. One such pathway of interest for MS is the DNA Repair
pathway. The DNA repair pathway consists of four sub-pathways. Briggs et al. [2010]
studied the pathways’ relationship with MS, using a mixture of machine learning (Random
Forests) and parametric modeling (Logistic Regression). The results suggested that the
only important gene in the pathway is GTF2H4, which is located within MHC region of
chromosome 6. However, the results were not definitive, and using the same data, the same
pathways were reanalyzed using the current method.
In pathway analysis the observed unit is still individual SNPs, but the unit of interest
is now a collection of genes. Methodologically, the approach is the same as analyzing a
gene, except the number of SNPs are increased. A SuperLearner was fit using the same
candidates as above. The four pathways were analyzed separately and the results are
shown in Table 3. The only associated pathway is the NER pathway, which contains
GTF2H4. Analyzing GTF2H4 independently, revealed an association very close to the
full NER association. Finally, analyzing the NER pathway without GTF2H4 revealed no
association. These results are a more definitive confirmation of the findings in Briggs et al.
[2010] that GTF2H4 is the only important component of the DNA Repair pathways as it
relates to MS.
23
Hosted by The Berkeley Electronic Press
Pathway Num Genes (SNPs) Z-Statistic P-value
BER 22 (127) 0.12 0.55
HR 15 (124) -0.29 0.38
NHEJ 9 (90) -0.97 0.17
NER 26 (208) -3.12 9.03× 10−4
NER (w/out GTF2H4) 197 -0.68 0.25
GTF2H4 only 11 -3.79 7.53× 10−5
Table 3: Results for the DNA Repair pathway analysis. Only the NER pathway shows any
association with MS. However, upon further examination that association is based entirely
on GTF2H4 confirming the results in Briggs et al. [2010].
6.2.3 Clustering the MHC
To illustrate the flexibility of this method to genetic data a very different analysis was
performed. Instead of testing the association of a region, the predictions were used to
cluster genes. As mentioned, the MHC region of chromosome 6 is well known to be highly
associated with MS (as well as many other auto-immune diseases). While the gene based
analysis revealed that almost every MHC gene had an association (often very strong ones),
one question of interest is whether these associations are due to the strong and complex
correlation (LD) in the MHC or are independent signals. While HLA-DRA is known
to be associated with MS, recent studies have suggested that other genes may also be
independently associated (e.g. Cree et al. [2010]).
In order to explore this question a novel approach was taken. The predictions (fˆ(X))
were calculated for each of the 78 MHC genes in the dataset. Then using the predictions
of just those with disease (n = 1343) all of the genes were clustered using the partitioning
around medoids (PAM) algorithm. PAM is similar to k-means clustering, with the primary
difference being, instead of minimizing an average distance, a median distance is minimized,
making the findings more robust. The MHC can be divided into three classes. Therefore
the number of centers, k, was chosen to be 3. Since the goal was to capture the correlation
among the predictions, a correlation based distance was used.
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Figure 8 shows the clusters of the 78 MHC genes. The genes, are ordered by their
position on Chromosome 6. The groupings of genes clearly correspond to their position,
suggesting that the correlation between the fˆ(X) is maintained through the position. Of
greater interest, the cluster memberships correspond fairly well with the three MHC classes.
To explore the question of whether these clusters represented independent signals, a
SuperLearner was trained using the SNPs in each of the three clusters, using the same
procedures of above. The interest was not in whether each cluster is associated with MS
(each clearly is), but whether the associations represent distinct signals. Table 4 shows
the correlation matrix for the three clusters. While there is positive correlation between
all three classes, Class I and Class II genes appear to be fairly independent of one another
compared to Class III (which is physically located in between Class I & II). This suggests
that there may be two separate associations within the MHC for MS. While this analysis
does not represent a confirmation of independent signals, like previous analyses, it does
correspond to previous analyses that they may exist.
Class I Class II Class III
Class I 1.000 0.175 0.410
Class II 0.175 1.000 0.516
Class III 0.410 0.516 1.000
Table 4: Correlation matrix of the fˆ(X) from the three MHC clusters, corresponding to
the three MHC classes. Class I & II appear to be somewhat independent, suggesting that
there may be two independent signals within the MHC for MS.
6.3 Thoughts on Application to Genetic Data
Three different applications to genetic data were illustrated, highlighting the flexibil-
ity of this approach. One particular challenge to this method is the ability to create
a strong predictor using genetic data. The influence of ones genetics on disease (i.e.
P (Disease|Genetics)) is going to be relatively low. For example, while MS has a strong
genetic component, its overall heritability is only estimated at 25% [Oksenberg and Bar-
cellos 2005]. Therefore, if a gene is in fact causative of disease, one would not expect the
P (D|G) to differ much from average risk. Therefore the true risk (θ) will not be much less
than the expected risk (θ∗) making detecting a significant association challenging.
Clayton [2009] looked at SNP data and noted that even highly associated SNPs have
low predictive ability. However, Kooperberg et al. [2010] recently showed, that creating
prediction models using SNPs that do not have strong marginal associations, does improve
the models. This is essentially the approach undertaken here, using all SNPs within a region
regardless of their marginal association. Even so, it is possible that the weak associations
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detected in the candidate gene analysis, may not be indicative of a lack of effect, but simply
a weak predictive ability of the SNPs in those genes.
7 Conclusion
The proposed method represents a powerful, flexible and semi-parametric approach to test-
ing the relationship between a set of variables and an outcome. It has applicability both
within the fields of prediction and machine learning as well as classical statistical inference.
From a machine learning perspective, it represents a means of assessing whether the pre-
dictive ability of a set of predictors is better than what would be expected by chance. This
represents an important but often unasked question of whether one should even attempt
to construct a predictor from the given data. From an inferential perspective, it represents
a means to assess whether a set of variables is related to an outcome. Traditional method-
ology is aimed at assessing the relationship between one covariate and one outcome. This
allows one to look at multiple variables at once. This is particularly important in fields
like genetics and the social sciences where one often has data on one level (e.g. SNPs,
social variables) and wants to make inference on another level that aggregates the data
(i.e. genes, SES). Such aggregation is often the only approach, as many times the level one
wants to make inference on, represents a construct and not an actual observable variable.
The constructed test statistic is a Wald statistic, using influence curves to calculate
the inference. A finite sample correction was necessary to appropriately scale the variance.
While the current correction is somewhat adhoc it conforms with other current work in the
area. An important area of further investigation is a formalized correction. For perspective,
the test-statistic has been compared to the F-test used in linear regression. In this sense it
can be thought of generalized goodness-of-fit test. Simulation results show the relationship
to the F-test, but also how it is more powerful under a variety of alternatives.
A range of applications to genetic data were illustrated. The first involved testing
the association of gene (and pathway) with disease. A more comprehensive simulation
illustrated how this is more powerful than typical approaches under complex associations.
While the candidate gene analysis was not able to reveal associations greater than what
would be expected by chance, examination of results did reveal that genes that would not
be identified by traditional approaches had strong associations. An analysis of genetic
pathways was able to more strongly confirm results in a previous study that were merely
speculated upon. A final analyses illustrated the variety of questions that could be ad-
dressed with this data. Using the same dataset, the goal was to find clusters of genes
in the MHC. The clusters corresponded almost perfectly with biological understanding
and the results provided insight that there may be two independent sources of association
within the MHC for MS.
In all, this method represents an important contribution to a range of statistical applica-
tions, filling a need within both statistical learning and inferential statistics. It effectively
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expands the range of questions that one can ask of their data and should represent an
important tool for many analyses.
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